ArticleScience China. Life sciences2026
ATF6α mediates Cr(VI)-induced acute hepatotoxicity via GRP78-dependent mitochondrial dysfunction under oxidative stress.
Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute exposure to the common environmental toxin, hexavalent chromium (Cr(VI)), can cause severe chemical hepatotoxicity. Although endoplasmic reticulum (ER) stress is closely associated with Cr(VI)-induced liver damage, the underlying mechanism requires further investigation. In this study, mice and hepatocytes exposed to Cr(VI) were used to analyze the effects of reactive oxygen species (ROS)-mediated ER stress on acute liver injury, with a particular focus on the activating transcription factor 6 (ATF6) branch. It was found that Cr(VI) stimulated the expression and cleavage of ATF6α, while the level of ATF6β was decreased. Pharmacological inhibition and gene knockdown of ATF6α alleviated liver damage caused by Cr(VI). Mechanistically, cleaved ATF6α translocated to the nucleus and directly bound to the promoter of HSPA5 to induce GRP78 transcription, which was closely related to mitochondrial impairment. HSPA5 interference in Cr(VI)-exposed hepatocytes partially improved mitochondrial homeostasis and mitochondria-dependent apoptosis. Interestingly, suppression of ATF6β increased site 1 protease (S1P) but not site 2 protease (S2P), promoting ATF6α cleavage in the Golgi apparatus. Overall, these findings establish ATF6α as a key regulator of Cr(VI)-induced hepatotoxicity via GRP78-mediated mitochondrial dysfunction under oxidative ER stress, suggesting the therapeutic potential of targeting the ATF6 pathway in xenobiotic-induced hepatic injury.
Indexed as
Identifiers
42891912What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.